425: Strive CFO Updates on Proposed Semler Scientific Merger

Strive, Inc. CFO Ben Pham posted an update on X.com regarding the proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statements and associated risks.

Summary

• Strive, Inc. CFO Ben Pham communicated on X.com on September 22, 2025, regarding the proposed business combination with Semler Scientific, Inc.
• The communication serves as a cautionary statement concerning forward-looking statements related to the merger.
• It highlights potential strategic and financial benefits, expected impact on future financial performance, timing of closing, and integration success as forward-looking statements.
• Numerous risks and uncertainties are detailed, which could cause actual results to differ materially from anticipated outcomes.
• Strive intends to file a Registration Statement on Form S-4, including an Information Statement/Proxy Statement/Prospectus, with the SEC to register Class A common stock for the transaction and seek Semler Scientific stockholder approval.

Sentiment

Score: 5

Explanation: The filing is a standard cautionary statement regarding a proposed business combination, outlining potential strategic benefits alongside a comprehensive list of risks and uncertainties. The tone is legally cautious rather than overtly positive or negative, which is typical for such disclosures.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are a potential outcome of the merger.

Negatives

• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Potential adverse reactions from customers or changes to business/employee relationships could arise from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing could negatively impact the deal.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both of Strive and Semler Scientific to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with Bitcoin and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement, particularly concerning Bitcoin treasury strategies.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The proposed transaction is expected to yield strategic and financial benefits, including anticipated cost savings and strategic gains, and impact the combined company's future financial performance. The timing of the closing and the ability to successfully integrate the businesses are also part of the forward outlook, though these are subject to significant risks and uncertainties.

Management Comments

• Ben Pham, Chief Financial Officer of Strive, Inc., posted the communication on X.com on September 22, 2025, in connection with the proposed business combination with Semler Scientific, Inc.

Industry Context

The filing mentions 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets,' indicating Strive's engagement with the evolving digital asset landscape, which is a notable trend for some companies in the current market.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a potential risk factor for the proposed transaction.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is set forth in its definitive proxy statement for its 2025 Annual Meeting of Stockholders, which was filed with the SEC on July 17, 2025.

Stakeholder Impact

• Potential adverse reactions from Strive's or Semler Scientific's customers.
• Potential changes to business or employee relationships.
• Dilution for Strive's Class A common stockholders due to the issuance of new shares.
• Semler Scientific stockholders will be required to approve the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.

Key Dates

Keywords

Strive, Semler Scientific, merger, business combination, SEC filing, Form 425, forward-looking statements, risk factors, corporate governance, Bitcoin treasury, digital assets, stock issuance, shareholder approval